Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
Clinical Pharmacokinetics
|
September 13, 2014
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration
Ahmed A Othman, Jonathan Q Tran, Meina T Tang, et al.
Clinical Pharmacokinetics
|
February 24, 2017
Clinical Pharmacokinetics of Ombitasvir
Prajakta S Badri, Diana L Shuster, Sandeep Dutta, et al.
Clinical Pharmacology in Drug Development
|
May 21, 2016
A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
Ahmed A Othman, Howard Cheskin, Charles Locke, et al.
Epilepsy Research
|
February 11, 2003
Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation
Sandeep Dutta, James C Cloyd, G Richard Granneman, et al.
Journal of Clinical Pharmacology
|
September 9, 2014
Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative pain
Wei Liu, Sandeep Dutta, Greg Kearns, et al.
Journal of Parkinson'S Disease
|
February 18, 2017
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
Ahmed A Othman, Matthew Rosebraugh, Krai Chatamra, et al.
Journal of Pharmaceutical Sciences
|
July 30, 2005
Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC)
Sandeep Dutta, Yihong Qiu, Emil Samara, et al.
Psychopharmacology
|
September 27, 2015
Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436
David A Katz, Wei Liu, Charles Locke, et al.
Journal of Clinical Pharmacology
|
May 23, 2002
Single- and multiple-dose pharmacokinetics of fiduxosin under nonfasting conditions in healthy male subjects
Sandeep Dutta, Yiming Zhang, Daniel J Daszkowski, et al.
Clinical Pharmacokinetics
|
March 5, 2017
Clinical Pharmacokinetics of Dasabuvir
Jennifer R King, Jiuhong Zha, Amit Khatri, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
Clinical Pharmacokinetics
|
September 13, 2014
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration
Ahmed A Othman, Jonathan Q Tran, Meina T Tang, et al.
Clinical Pharmacokinetics
|
February 24, 2017
Clinical Pharmacokinetics of Ombitasvir
Prajakta S Badri, Diana L Shuster, Sandeep Dutta, et al.
Clinical Pharmacology in Drug Development
|
May 21, 2016
A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
Ahmed A Othman, Howard Cheskin, Charles Locke, et al.
Epilepsy Research
|
February 11, 2003
Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation
Sandeep Dutta, James C Cloyd, G Richard Granneman, et al.
Journal of Clinical Pharmacology
|
September 9, 2014
Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative pain
Wei Liu, Sandeep Dutta, Greg Kearns, et al.
Journal of Parkinson'S Disease
|
February 18, 2017
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
Ahmed A Othman, Matthew Rosebraugh, Krai Chatamra, et al.
Journal of Pharmaceutical Sciences
|
July 30, 2005
Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC)
Sandeep Dutta, Yihong Qiu, Emil Samara, et al.
Psychopharmacology
|
September 27, 2015
Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436
David A Katz, Wei Liu, Charles Locke, et al.
Journal of Clinical Pharmacology
|
May 23, 2002
Single- and multiple-dose pharmacokinetics of fiduxosin under nonfasting conditions in healthy male subjects
Sandeep Dutta, Yiming Zhang, Daniel J Daszkowski, et al.
Clinical Pharmacokinetics
|
March 5, 2017
Clinical Pharmacokinetics of Dasabuvir
Jennifer R King, Jiuhong Zha, Amit Khatri, et al.
Page
of 12